Key facts
- This page summarizes Jonathan P. Siegrist's Form 4 filing for QuidelOrtho Corp (QDEL).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2026, 19:50.
Jonathan P. Siegrist - 30 Jan 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)
- Reporting relationship
- EVP of R&D & CTO
- Issuer ticker
- QDEL
- Reported as of
- 30 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2026, 19:50:22 UTC
- Prior SEC filing
- 02 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Ahn, attorney-in-fact for Jonathan P. Siegrist
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jonathan P. Siegrist filed Form 4 for QuidelOrtho Corp (QDEL) on 03 Feb 2026.
Change
- Previous filing in this sequence was filed on 02 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002040321
Primary reporting owner
Siegrist Jonathan Philip
- Relationship
- EVP of R&D & CTO
- Address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO
- Signature
- /s/ Jennifer Ahn, attorney-in-fact for Jonathan P. Siegrist
- Signature date
- 03 Feb 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QDEL
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +36,152
- Change %
- Price
- $0.000000
- Shares after
- 36,152
- Date
- 30 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,152
- Exercise price
- Footnotes
- F1, F2
QDEL
transaction
Derivative
Non-Qualified Stock Options
Award
- Transaction value
- $0
- Shares
- +36,150
- Change %
- Price
- $0.000000
- Shares after
- 36,150
- Date
- 30 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,150
- Exercise price
- $27.17
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation Common Stock.
Footnote F2
12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.
Footnote F3
36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.